#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14966	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2185	681.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1463	1463	C	871	C	814	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27164	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3457	782.6	0	.	n	.	0	A20C	SNP	20	20	A	271	271	C	483	C	464	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27164	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3457	782.6	0	.	n	.	0	T695C	SNP	695	695	T	946	946	C	849	C,T	804,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27164	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3457	782.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1889	1889	G	902	G	856	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27164	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3457	782.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2222	2222	C	929	C,A	866,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27164	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3457	782.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2296	2296	A	893	A	853	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27164	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3457	782.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2848	2848	C	862	C	825	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27164	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3457	782.6	0	HET	.	.	.	A412G,C	.	412	412	A	663	663	A	825	A,G,C	573,193,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2036	folP	855	855	100.0	folP.l15.c4.ctg.1	1695	119.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1033	1035	AGC	216;214;216	A;G;C	210;208;209	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5298	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3520	150.0	1	SNP	p	S91F	1	.	.	271	273	TTC	669	671	TTC	197;196;197	T;T;C	188;189;189	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5298	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3520	150.0	1	SNP	p	D95G	1	.	.	283	285	GGC	681	683	GGC	195;194;194	G;G;C	187;186;184	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5298	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3520	150.0	1	SNP	p	G95N	0	.	.	283	285	GGC	681	683	GGC	195;194;194	G;G;C	187;186;184	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1684	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1428	117.0	0	.	p	.	0	F184L	NONSYN	550	552	TTC	867	869	TTG	198;198;197	T;T;G	188;188;185	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1684	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1428	117.0	1	SNP	p	G45D	0	.	.	133	135	GGC	450	452	GGC	192;192;193	G;G;C	184;183;184	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	832	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1087	76.3	0	.	n	.	0	A197.	DEL	197	197	A	599	599	A	187	A	175	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	177.5	1	SNP	p	D86N	0	.	.	256	258	GAC	504	506	GAC	212;212;212	G;A;C	199;195;202	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	177.5	1	SNP	p	S87R	1	.	.	259	261	CGT	507	509	CGT	212;210;211	C;G,A;T	200;196,1;201	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	177.5	1	SNP	p	R87I	0	.	.	259	261	CGT	507	509	CGT	212;210;211	C;G,A;T	200;196,1;201	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	177.5	1	SNP	p	R87W	0	.	.	259	261	CGT	507	509	CGT	212;210;211	C;G,A;T	200;196,1;201	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	177.5	1	SNP	p	S88P	0	.	.	262	264	TCC	510	512	TCC	210;211;211	T;C;C	199;199;200	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4368	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2931	148.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1643	1645	GGC	207;203;201	G;G;C	192;188;185	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1300	1302	GCA	250;253;254	G;C;A	235;234;238	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1303	1305	ATC	256;255;255	A,G;T;C	239,1;243;242	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1315	1317	GTG	250;247;248	G;T;G	236;233;233	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1315	1317	GTG	250;247;248	G;T;G	236;233;233	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1819	1821	ACC	191;192;193	A;C;C	177;180;182	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1873	1875	GCG	193;194;197	G;C,G;G	163;147,1;158	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1873	1875	GCG	193;194;197	G;C,G;G	163;147,1;158	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1996	1998	AGC	166;164;164	A;G;C	158;155;156	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2005	2007	GGC	161;160;161	G;G;C	152;149;148	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4056	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2468	163.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2023	2025	CCG	130;131;133	C,CG;C;G,T	97,1;102;105,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5766	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3171	181.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1636	1638	CTG	213;212;211	C;T;G	201;199;197	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2072	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1897	108.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	643	643	C	130	C	125	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	422	424	GAA	227;229;228	G;A;A	214;216;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	833	835	TCA	238;236;237	T;C;A	225;228;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	962	964	GTC	241;242;246	G;T;C	219;220;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	974	976	TCT	245;242;246	T;C;T	229;231;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1292	1294	GCA	204;203;202	G;C;A	189;191;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	1	SNP	p	G120K	1	.	.	358	360	AAG	668	670	AAG	235;236;236	A;A;G	221;222;220	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	1	SNP	p	A121D	1	.	.	361	363	GAC	671	673	GAC	235;234;233	G,C;A;C	217,1;219;220	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1499	189.3	1	SNP	p	D121N	0	.	.	361	363	GAC	671	673	GAC	235;234;233	G,C;A;C	217,1;219;220	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10344	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4998	206.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1140	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1038	109.1	1	SNP	p	V57M	1	.	.	169	171	ATG	477	479	ATG	218;220;218	A;T;G	206;209;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
